Shearman & Sterling advised Citigroup as financial advisor to leading healthcare solutions provider Analogic Corporation on its $1.1 billion acquisition by an affiliate of Altaris Capital Partners, a leading private investment firm with expertise in Analogic’s end markets.  Analogic will be acquired by Altaris for $84.00 per share in cash and will become a privately held company upon the transaction’s completion.

Expected to close in mid-2018, the transaction is subject to approval by Analogic stockholders, regulatory approval and other customary closing conditions.

The Shearman & Sterling team included associate Christopher Glenn (both New York-Mergers & Acquisitions).